Supplement
Collagen peptides
Hydrolysed collagen is one of the best-selling peptide products in the world, and unusually for the peptide category it is a legal food supplement with a genuine randomised-trial literature. That literature has two consistent features worth knowing before reading any grade: the outcomes are instrument measurements of skin or specific functional endpoints rather than health outcomes, and much of it is funded by collagen manufacturers.
Quick verdict
Replicated randomised trials, summarised by meta-analysis, indicate oral collagen improves instrument-measured skin elasticity and hydration. Narrower single trials suggest benefits for activity-related joint pain and for training-related muscle gains in elderly men. Nothing links collagen to lifespan, and most supporting trials are industry-funded.
The assessment
Claim by claim
Each claim is graded on its own evidence. A grade for one claim says nothing about the others.
| Claim | What was measured | Evidence |
|---|---|---|
| Improves instrument-measured skin elasticity and hydration | Surrogate biomarker | Moderate |
| Reduces activity-related joint pain | Physical function | Early |
| Adds to muscle and strength gains from resistance training in elderly men | Physical function | Early |
| Slows ageing or extends human lifespan | Lifespan | Insufficient |
Improves instrument-measured skin elasticity and hydration
Moderate human evidenceOutcome measured: Surrogate biomarker — A laboratory marker measured as a stand-in for health. A change here does not by itself demonstrate a health benefit.
This is collagen's best-supported claim: randomised placebo-controlled trials, summarised by a 2021 systematic review and meta-analysis, consistently report improvements in cutometer-measured skin elasticity and hydration after 8–12 weeks. The honest framing: these are instrument readings of skin properties, replicated but modest, not a health outcome.
Why this grade — the appraisal in full
More than one human trial pointing the same way, but limited by sample size, duration, risk of bias, or reliance on surrogate endpoints.
- Strongest study design. Meta-analysis of RCTs with 1,125 participants.
- Human research volume. 3 human studies, 1,308 participants in total.
- What was measured. Human studies measured surrogate biomarkers only. A change in a marker is not by itself a demonstrated health benefit.
- Replication. Findings point the same way in 3 independent human studies.
- Study duration. Longest human study ran 12 weeks.
- Funding and conflicts. 2 of 3 human studies were funded by, or authored by, a party with a commercial interest in the result.
Limitations. Most trials are funded by collagen manufacturers, effect sizes are modest, and the endpoints are laboratory measurements of skin rather than anything about health or ageing. The meta-analysis authors themselves noted heterogeneity across included studies.
| Study | Design | Population | Finding |
|---|---|---|---|
| [1]Effects of hydrolyzed collagen supplementation on skin aging: a systematic revie…International journal of dermatology · 2021 · PMID 33742704 | Meta-analysis of RCTsHuman | 1,125 participantsHealthy participants | Supports the claimSystematic review and meta-analysis of 19 RCTs of hydrolysed collagen for skin ageing endpoints; favourable results for hydration and elasticity, with noted heterogeneity. |
| [2]Oral supplementation of specific collagen peptides has beneficial effects on hum…Skin pharmacology and physiology · 2014 · PMID 23949208 | Randomised controlled trialHuman | 69 participantsHealthy participants | Supports the claimDouble-blind placebo-controlled RCT; improved skin elasticity at 4 and 8 weeks. Industry-supported. |
| [3]Oral intake of specific bioactive collagen peptides reduces skin wrinkles and in…Skin pharmacology and physiology · 2014 · PMID 24401291 | Randomised controlled trialHuman | 114 participantsHealthy participants | Supports the claimDouble-blind placebo-controlled RCT; reduced eye-wrinkle depth and increased dermal matrix markers. Industry-supported. |
Reduces activity-related joint pain
Early human evidenceOutcome measured: Physical function — A measured capability such as walking speed, grip strength or VO₂ max.
A 24-week randomised trial in athletes with activity-related joint pain reported less pain on collagen hydrolysate than placebo. It remains the reference trial for this claim — a single study, in a specific population, funded by a manufacturer.
Why this grade — the appraisal in full
One or a small number of small, short or preliminary human studies. Directionally interesting, not yet dependable.
- Strongest study design. Randomised controlled trial with 147 participants.
- Human research volume. 1 human study, 147 participants in total.
- What was measured. 1 human study measured a clinical or functional outcome rather than a laboratory marker alone.
- Replication. The supporting result has not been independently replicated in humans.
- Study duration. Longest human study ran 24 weeks.
- Funding and conflicts. 1 of 1 human studies were funded by, or authored by, a party with a commercial interest in the result.
Limitations. One randomised trial in young athletes; no independent replication in older adults with age-related joint symptoms, which is who most collagen buyers are.
| Study | Design | Population | Finding |
|---|---|---|---|
| [4]24-Week study on the use of collagen hydrolysate as a dietary supplement in athl…Current medical research and opinion · 2008 · PMID 18416885 | Randomised controlled trialHuman | 147 participantsHealthy participants | Supports the claim24-week RCT in athletes with activity-related joint pain; less pain on collagen hydrolysate. Industry-funded. |
Adds to muscle and strength gains from resistance training in elderly men
Early human evidenceOutcome measured: Physical function — A measured capability such as walking speed, grip strength or VO₂ max.
A randomised trial in sarcopenic elderly men found greater gains in fat-free mass and strength when twelve weeks of resistance training was combined with collagen peptides rather than placebo. Interesting and directly relevant to ageing — and still awaiting independent replication.
Why this grade — the appraisal in full
One or a small number of small, short or preliminary human studies. Directionally interesting, not yet dependable.
- Strongest study design. Randomised controlled trial with 53 participants.
- Human research volume. 1 human study, 53 participants in total.
- What was measured. 1 human study measured a clinical or functional outcome rather than a laboratory marker alone.
- Replication. The supporting result has not been independently replicated in humans.
- Study duration. Longest human study ran 12 weeks.
- Funding and conflicts. 1 of 1 human studies were funded by, or authored by, a party with a commercial interest in the result.
Limitations. Single trial of 53 men from one research group; collagen is a low-quality protein by amino-acid profile, and no trial has shown it outperforms ordinary whey for this purpose.
| Study | Design | Population | Finding |
|---|---|---|---|
| [5]Collagen peptide supplementation in combination with resistance training improve…The British journal of nutrition · 2015 · PMID 26353786 | Randomised controlled trialHuman | 53 participantsParticipants with a diagnosed condition | Supports the claimRCT in sarcopenic elderly men; collagen peptides plus resistance training improved body composition and strength versus training alone. |
Slows ageing or extends human lifespan
Insufficient evidenceOutcome measured: Lifespan — Death from any cause was measured.
No study has tested this. Collagen's trials measure skin instruments, joint pain and body composition over weeks — the 'anti-ageing' framing on the label is a marketing extension of those narrow results.
Why this grade — the appraisal in full
Too little credible research exists to judge the claim either way.
- Available research. No usable studies are linked to this claim.
Limitations. No human or animal study links collagen supplementation to lifespan or healthspan.
Human evidence
5 studies in people.
- [1]Meta-analysis of RCTs · 1,125 participants
- [2]Randomised controlled trial · 69 participants
- [3]Randomised controlled trial · 114 participants
- [4]Randomised controlled trial · 147 participants
- [5]Randomised controlled trial · 53 participants
Animal and laboratory evidence
Shown separately, and never used to support a human claim.
No preclinical study is currently linked on this page.
Before anything else
Safety and interactions
A food-derived protein consumed for decades with a good tolerability record in trials; the main cautions are sourcing allergies (fish, shellfish, egg) and that it is not suitable for vegetarians or vegans — no plant-derived collagen exists, whatever the label implies.
Practical guidance
If you decide to buy
The honest purchase case is narrow and cosmetic-functional: instrument-measured skin elasticity and, on thinner evidence, joint comfort and training support. Buy it for those, knowing the trials are mostly manufacturer-funded — not for ageing itself.
- Which form
- Hydrolysed collagen peptides (collagen hydrolysate). Marine and bovine sources perform similarly in trials; 'vegan collagen' is not collagen.
- Typical evidence-aligned dose
- Trials used 2.5–15 g per day; the skin studies mostly 2.5–10 g daily for 8–12 weeks. It dissolves in anything; timing does not matter.
- Quality and testing
- Collagen is a commodity — prefer a supplier stating the source species and batch testing for heavy metals; marine collagen quality varies most.
- Buying in the UK
- Widely available in UK supermarkets and pharmacies at commodity prices. If a product's marketing leans on 'anti-ageing' rather than skin measurements, it is claiming more than the evidence shows.
Disclosure: Longevity Record is commercially connected to Vitality Supplements. This guidance names no brands, links to no shop, and is written from the trial literature — the grades above were computed before this section was, and no commercial consideration can change them.
The ledger
Grade history
22 August 2026
First published appraisal of this claim. Study links added: PMID 23949208, PMID 24401291, PMID 33742704.
22 August 2026
First published appraisal of this claim. Study links added: PMID 18416885.
22 August 2026
First published appraisal of this claim. Study links added: PMID 26353786.
22 August 2026
First published appraisal of this claim.
Falsifiability
What would change our view
Independent (non-industry-funded) randomised trials on the skin and joint endpoints, or any randomised evidence connecting collagen supplementation to a health outcome rather than an instrument measurement.
Check everything
Sources
Every citation links to its PubMed record. Bibliographic details are retrieved from PubMed, not written by us.
- [1]Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis de Miranda RB, Weimer P, Rossi RC. International journal of dermatology. 2021. PMID 33742704 · doi:10.1111/ijd.15518
- [2]Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study Proksch E et al.. Skin pharmacology and physiology. 2014. PMID 23949208 · doi:10.1159/000351376
- [3]Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis Proksch E et al.. Skin pharmacology and physiology. 2014. PMID 24401291 · doi:10.1159/000355523
- [4]24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain Clark KL et al.. Current medical research and opinion. 2008. PMID 18416885 · doi:10.1185/030079908x291967
- [5]Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men: a randomised controlled trial Zdzieblik D et al.. The British journal of nutrition. 2015. PMID 26353786 · doi:10.1017/S0007114515002810